Top Insider Purchases of the Month -
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Share Price |
Shares Traded |
Shares Owned |
Own chg |
Value Traded |
1d ret |
1w ret |
1m ret |
6m ret |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2018-04-17 | AKCA | Akcea Therapeutics, Inc. | Ionis Pharmaceuticals Inc | 10% | P - Purchase | $18.75 | +10,666,666 | 64,114,545 | +20% | +$199,999,988 | ||||||
| M | 2018-04-03 | CTL | Centurylink, Inc | Temasek Holdings (Private) Ltd | 10% | P - Purchase | $16.72 | +7,620,118 | 118,164,323 | +7% | +$127,373,456 | |||||
2018-04-05 | CTL | Centurylink, Inc | Temasek Holdings (Private) Ltd | 10% | P - Purchase | $17.41 | +5,036,884 | 123,201,207 | +4% | +$87,700,209 | ||||||
2018-04-13 | AVGO | Broadcom Inc. | Silver Lake Group, L.L.C. | Dir | P - Purchase | $247.94 | +344,761 | 2,049,296 | +20% | +$85,478,486 | ||||||
2018-04-19 | AFSI | Amtrust Financial Services, Inc. | Zyskind Barry D | COB, Pres, CEO, 10% | P - Purchase | $12.62 | +2,945,113 | 2,945,113 | New | +$37,152,600 | ||||||
2018-04-09 | ICPT | Intercept Pharmaceuticals Inc | Genextra S.P.A. | 10% | P - Purchase | $64.00 | +390,625 | 6,845,578 | +6% | +$25,000,000 | ||||||
2018-04-09 | ICPT | Intercept Pharmaceuticals Inc | Micheli Francesco | 10% | P - Purchase | $64.00 | +390,625 | 6,845,578 | +6% | +$25,000,000 | ||||||
2018-04-11 | CATM | Cardtronics Plc | Hudson Executive Capital LP | 10% | P - Purchase | $23.55 | +958,355 | 7,346,185 | +15% | +$22,569,260 | ||||||
2018-04-02 | MYOV | Myovant Sciences Ltd. | Viking Global Performance LLC | 10% | P - Purchase | $20.27 | +1,110,015 | 38,341,357 | +3% | +$22,500,004 | ||||||
2018-04-02 | MYOV | Myovant Sciences Ltd. | Qvt Associates Gp LLC | See remarks, 10% | P - Purchase | $20.27 | +1,110,015 | 38,341,357 | +3% | +$22,500,004 | ||||||
2018-04-02 | MYOV | Myovant Sciences Ltd. | Dexxon Holdings Ltd. | 10% | P - Purchase | $20.27 | +1,110,015 | 38,341,357 | +3% | +$22,500,004 | ||||||
2018-04-02 | MYOV | Myovant Sciences Ltd. | Lo Andrew | 10% | P - Purchase | $20.27 | +1,110,015 | 38,341,357 | +3% | +$22,500,004 | ||||||
2018-04-02 | MYOV | Myovant Sciences Ltd. | Svf Investments (Uk) Ltd | 10% | P - Purchase | $20.27 | +1,110,015 | 38,341,357 | +3% | +$22,500,004 | ||||||
2018-04-02 | MYOV | Myovant Sciences Ltd. | Roivant Sciences Ltd. | 10% | P - Purchase | $20.27 | +1,110,015 | 38,341,357 | +3% | +$22,500,004 | ||||||
2018-04-02 | MYOV | Myovant Sciences Ltd. | Viking Global Investors LP | 10% | P - Purchase | $20.27 | +1,110,015 | 38,341,357 | +3% | +$22,500,004 | ||||||
2018-04-02 | MYOV | Myovant Sciences Ltd. | Machado Patrick | 10% | P - Purchase | $20.27 | +1,110,015 | 38,341,357 | +3% | +$22,500,004 | ||||||
| D | 2018-04-02 | FIXX | Homology Medicines, Inc. | Flynn James E | *Director by Deputization, 10% | P - Purchase | $16.00 | +1,250,000 | 5,227,035 | +31% | +$20,000,000 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Barris Peter J | 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Barrett M James | 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | New Enterprise Associates 14, L.P. | 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Viswanathan Ravi | 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Sonsini Peter W. | 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Sandell Scott D | 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Mott David M | Dir, 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Kerins Patrick J | 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Florence Anthony A. Jr. | 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| M | 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Baskett Forest | 10% | P - Purchase | $1.92 | +6,571,164 | 79,978,672 | +9% | +$12,587,753 | |||||
| D | 2018-02-28 | AUSI | Aura Systems Inc | Breslow Warren | 10% | P - Purchase | $1.62 | +7,447,178 | 7,682,751 | >999% | +$12,064,428 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Novartis Institutes For Biomedical Research, Inc. | 10% | P - Purchase | $15.00 | +766,666 | 3,948,482 | +24% | +$11,499,990 | |||||
2018-04-13 | ANGI | Angi Homeservices Inc. | Luxor Capital Group, LP | 10% | P - Purchase | $13.50 | +807,465 | 12,956,595 | +7% | +$10,900,778 | ||||||
| A | 2018-04-13 | ANGI | Angi Homeservices Inc. | Luxor Capital Group, LP | 10% | P - Purchase | $13.50 | +807,465 | 12,453,667 | +7% | +$10,900,778 | |||||
| D | 2018-04-02 | FIXX | Homology Medicines, Inc. | Temasek Holdings (Private) Ltd | 10% | P - Purchase | $16.00 | +625,000 | 3,220,293 | +24% | +$10,000,000 | |||||
2018-03-28 | PSDV | Eyepoint Pharmaceuticals, Inc. | Ew Healthcare Partners, L.P. | 10% | P - Purchase | $1.10 | +8,606,324 | 17,212,648 | +100% | +$9,466,956 | ||||||
2018-04-20 | CATM | Cardtronics Plc | Hudson Executive Capital LP | 10% | P - Purchase | $25.39 | +350,500 | 7,696,685 | +5% | +$8,899,195 | ||||||
| M | 2018-03-23 | ANGI | Angi Homeservices Inc. | Luxor Capital Group, LP | 10% | P - Purchase | $13.80 | +480,912 | 11,455,630 | +4% | +$6,638,281 | |||||
| M | 2018-04-04 | ANGI | Angi Homeservices Inc. | Luxor Capital Group, LP | 10% | P - Purchase | $13.39 | +493,500 | 12,149,130 | +4% | +$6,607,417 | |||||
| D | 2018-04-03 | UMRX | Unum Therapeutics Inc. | Ratcliffe Liam | Dir | P - Purchase | $12.00 | +550,000 | 897,773 | +158% | +$6,600,000 | |||||
2018-03-23 | TRN | Trinity Industries Inc | Valueact Holdings, L.P. | 10% | P - Purchase | $32.08 | +196,691 | 21,407,891 | +1% | +$6,309,847 | ||||||
| M | 2018-04-19 | AKAO | Achaogen Inc | Duggan Robert W | 10% | P - Purchase | $13.06 | +468,337 | 7,023,076 | +7% | +$6,118,654 | |||||
| D | 2018-04-02 | FIXX | Homology Medicines, Inc. | Vida Ventures, LLC | 10% | P - Purchase | $16.00 | +375,000 | 770,845 | +95% | +$6,000,000 | |||||
2018-04-02 | DDR | Ddr Corp | Otto Alexander | Dir, 10% | P - Purchase | $7.31 | +711,616 | 52,860,079 | +1% | +$5,202,482 | ||||||
2018-03-29 | HRTX | Heron Therapeutics, Inc. /de/ | Tang Kevin C | Dir, 10% | P - Purchase | $26.00 | +192,308 | 8,546,503 | +2% | +$5,000,008 | ||||||
2018-03-28 | NVTA | Invitae Corp | Baker Bros. Advisors LP | 10% | P - Purchase | $4.50 | +1,111,111 | 7,553,553 | +17% | +$5,000,000 | ||||||
2018-03-28 | OCX | Oncocyte Corp | Broadwood Partners, L.P. | 10% | P - Purchase | $1.26 | +3,968,254 | 15,133,013 | +36% | +$5,000,000 | ||||||
| M | 2018-03-26 | DDR | Ddr Corp | Otto Alexander | Dir, 10% | P - Purchase | $6.98 | +666,097 | 51,377,564 | +1% | +$4,650,453 | |||||
| M | 2018-04-12 | ETM | Entercom Communications Corp | Field Joseph M | COB Emeritus | P - Purchase | $9.65 | +415,125 | 7,453,137 | +6% | +$4,005,105 | |||||
| D | 2018-04-02 | FIXX | Homology Medicines, Inc. | Rock Springs Capital Management LP | 10% | P - Purchase | $16.00 | +250,000 | 645,845 | +63% | +$4,000,000 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Lv Management Group, LLC | 10% | P - Purchase | $15.00 | +266,000 | 3,447,817 | +8% | +$3,990,000 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Shanafelt Armen | Dir, 10% | P - Purchase | $15.00 | +266,000 | 3,447,817 | +8% | +$3,990,000 | |||||
| DM | 2018-04-13 | EYEG | Eyegate Pharmaceuticals Inc | Armistice Capital, LLC | 10% | P - Purchase | $0.36 | +10,479,970 | 27,425,000 | +62% | +$3,740,050 | |||||
| M | 2018-03-23 | APPN | Appian Corp | Abdiel Capital Management, LLC | 10% | P - Purchase | $26.13 | +141,486 | 10,818,036 | +1% | +$3,697,453 | |||||
| M | 2018-04-09 | ETM | Entercom Communications Corp | Field Joseph M | COB Emeritus | P - Purchase | $9.70 | +375,000 | 7,038,012 | +6% | +$3,635,813 | |||||
2018-03-28 | THM | International Tower Hill Mines Ltd | Electrum Strategic Opportunities Fund II L.P. | 10% | P - Purchase | $0.50 | +6,676,852 | 26,571,380 | +34% | +$3,338,426 | ||||||
| M | 2018-04-02 | TIF | Tiffany & Co | Trapani Francesco | Dir | P - Purchase | $94.66 | +35,000 | 446,156 | +9% | +$3,313,255 | |||||
2018-03-26 | IFF | International Flavors & Fragrances Inc | Winder Investment Pte Ltd | 10% | P - Purchase | $134.54 | +23,304 | 10,573,497 | 0% | +$3,135,385 | ||||||
| M | 2018-04-09 | INFI | Infinity Pharmaceuticals, Inc. | Bvf Partners L P/il | 10% | P - Purchase | $1.97 | +1,510,000 | 950,473 | -270% | +$2,970,000 | |||||
2018-04-05 | ASPS | Altisource Portfolio Solutions S.A. | Deer Park Road Management Company, LP | 10% | P - Purchase | $25.93 | +111,516 | 3,056,643 | +4% | +$2,891,298 | ||||||
2018-03-29 | DDR | Ddr Corp | Otto Alexander | Dir, 10% | P - Purchase | $7.34 | +393,568 | 52,148,463 | +1% | +$2,888,081 | ||||||
| D | 2018-04-17 | VRML | Vermillion, Inc. | Schuler Jack W | 10% | P - Purchase | $1.00 | +2,838,090 | 13,416,342 | +27% | +$2,838,090 | |||||
2018-03-28 | DDR | Ddr Corp | Otto Alexander | Dir, 10% | P - Purchase | $7.24 | +377,331 | 51,754,895 | +1% | +$2,731,424 | ||||||
| M | 2018-03-28 | ANGI | Angi Homeservices Inc. | Luxor Capital Group, LP | 10% | P - Purchase | $13.54 | +200,000 | 11,655,630 | +2% | +$2,708,990 | |||||
2018-04-03 | IFF | International Flavors & Fragrances Inc | Winder Investment Pte Ltd | 10% | P - Purchase | $134.32 | +20,000 | 10,650,193 | 0% | +$2,686,476 | ||||||
2018-03-29 | ASPS | Altisource Portfolio Solutions S.A. | Deer Park Road Management Company, LP | 10% | P - Purchase | $26.18 | +101,359 | 2,945,127 | +4% | +$2,653,526 | ||||||
| D | 2018-04-04 | WINT | Windtree Therapeutics Inc /de/ | Lee'S Pharmaceutical Holdings Ltd | 10% | P - Purchase | $4.80 | +541,667 | 2,853,271 | +23% | +$2,600,002 | |||||
| M | 2018-03-28 | APPN | Appian Corp | Abdiel Capital Management, LLC | 10% | P - Purchase | $25.74 | +100,000 | 11,017,118 | +1% | +$2,574,000 | |||||
| M | 2018-04-13 | PDVW | Pdvwireless, Inc. | Owl Creek Asset Management, L.P. | 10% | P - Purchase | $30.00 | +74,048 | 4,862,650 | +2% | +$2,221,787 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Barris Peter J | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Growth Equity Opportunities Iv, LLC | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Viswanathan Ravi | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Sonsini Peter W. | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Sandell Scott D | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Sakoda Jon | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Mott David M | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Makower Joshua | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Florence Anthony A. Jr. | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| M | 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Baskett Forest | 10% | P - Purchase | $2.30 | +920,976 | 17,283,670 | +6% | +$2,115,036 | |||||
| D | 2018-04-17 | VRML | Vermillion, Inc. | Schuler Henri George | 10% | P - Purchase | $1.00 | +2,107,774 | 9,262,363 | +29% | +$2,107,774 | |||||
| M | 2017-11-28 | BOXL | Boxlight Corp | Kuo Wei-Wu | 10% | P - Purchase | $7.00 | +286,442 | 6,777,580 | +4% | +$2,005,094 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Viswanathan Ravi | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Sonsini Peter W. | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Sandell Scott D | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Mott David M | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Kerins Patrick J | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Baskett Forest | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Barris Peter J | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | Barrett M James | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
| D | 2018-04-23 | SURF | Surface Oncology, Inc. | New Enterprise Associates 14, L.P. | 10% | P - Purchase | $15.00 | +133,333 | 3,312,877 | +4% | +$1,999,995 | |||||
2018-04-16 | JPM | Jpmorgan Chase & Co | Hobson Mellody L | Dir | P - Purchase | $111.05 | +18,000 | 28,864 | +166% | +$1,998,814 | ||||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | New Enterprise Associates 14, L.P. | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | Viswanathan Ravi | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | Sonsini Peter W. | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | Sandell Scott D | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | Mott David M | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | Kerins Patrick J | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | Baskett Forest | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | Barris Peter J | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
| D | 2018-03-27 | TCON | Tracon Pharmaceuticals, Inc. | Barrett M James | 10% | P - Purchase | $2.70 | +707,964 | 3,466,003 | +26% | +$1,911,503 | |||||
2018-04-05 | RDUS | Radius Health, Inc. | Biotech Growth N V | 10% | P - Purchase | $36.58 | +50,000 | 5,903,799 | +1% | +$1,828,845 |
Real-time CSV? Options? Alerts? Contact us!
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |